{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:39:03Z","timestamp":1768005543332,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ctro.2025.100918","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:51:21Z","timestamp":1736556681000},"page":"100918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Associations of dose to the urethra and long-term patient-reported outcomes after radiotherapy with EBRT and HDR brachytherapy boost for prostate cancer"],"prefix":"10.1016","volume":"51","author":[{"given":"Lars","family":"Haack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Krug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justus","family":"Domschikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Wittenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severin","family":"Rodler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Nuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Schmalz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank-Andr\u00e9","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2025.100918_b0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2025.100918_b0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.euf.2023.03.020","article-title":"Late toxicities of prostate radiotherapy: can we further SMARTen up the therapeutic index?","volume":"9","author":"Safavi","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ctro.2025.100918_b0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00066-018-1395-y","article-title":"Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within arandomized controlled trial","volume":"195","author":"Rammant","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2025.100918_b0020","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(22)00544-7","article-title":"Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy","volume":"23","author":"Martin","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0025","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ijrobp.2010.04.046","article-title":"Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer","volume":"80","author":"Morton","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100918_b0030","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.ijrobp.2018.08.015","article-title":"A systematic post-QUANTEC review of tolerance doses for late toxicity after prostate cancer radiation therapy","volume":"102","author":"Olsson","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100918_b0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijrobp.2022.01.022","article-title":"Intraprostatic urethra: the new kid on the block for prostate cancer radiation therapy?","volume":"113","author":"Zilli","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100918_b0040","doi-asserted-by":"crossref","unstructured":"Ong WL, Hupman MA, Davidson M, Ruschin M, Detsky J, Liu S, et al. Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancer. ctRO 2024;45. https:\/\/doi.org\/10.1016\/j.ctro.2023.100722.","DOI":"10.1016\/j.ctro.2023.100722"},{"key":"10.1016\/j.ctro.2025.100918_b0045","doi-asserted-by":"crossref","unstructured":"Ratnakumaran R, Mohajer J, Withey SJ, Brand DH, Lee E, Loblaw A, et al. Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity. ctRO 2024;46. https:\/\/doi.org\/10.1016\/j.ctro.2024.100769.","DOI":"10.1016\/j.ctro.2024.100769"},{"key":"10.1016\/j.ctro.2025.100918_b0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.euo.2022.02.005","article-title":"Local failure after prostate SBRT predominantly occurs in the PI-RADS 4 or 5 dominant intraprostatic lesion","volume":"6","author":"Gorovets","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.clgc.2015.12.005","article-title":"Radiotherapy boost for the dominant intraprostatic cancer lesion-a systematic review and meta-analysis","volume":"14","author":"von Eyben","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ctro.2025.100918_b0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13014-023-02375-5","article-title":"Use of focal radiotherapy boost for prostate cancer: radiation oncologists\u2019 perspectives and perceived barriers to implementation","volume":"18","author":"Zhong","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0065","doi-asserted-by":"crossref","unstructured":"Gu\u00e9velou JL, Sargos P, Ost P, Alongi F, Arcangeli S, Berlin A, et al. Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey. ctRO 2024;0. https:\/\/doi.org\/10.1016\/j.ctro.2024.100907.","DOI":"10.1016\/j.ctro.2024.100907"},{"key":"10.1016\/j.ctro.2025.100918_b0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brachy.2013.11.002","article-title":"The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer\u2014a benchmark for high-tech external beam radiotherapy alone?","volume":"13","author":"Galalae","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2025.100918_b0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.brachy.2014.01.010","article-title":"Introduction of inverse dose optimization for ultrasound-based high-dose-rate boost brachytherapy: how we do it in Kiel","volume":"13","author":"Siebert","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2025.100918_b0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13014-019-1424-8","article-title":"The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapy","volume":"14","author":"Dekura","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0085","doi-asserted-by":"crossref","unstructured":"Spyrou A, Martin A-G, Hannoun-L\u00e9vi J-M, Stewart A. Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how. ctRO 2024;49. https:\/\/doi.org\/10.1016\/j.ctro.2024.100870.","DOI":"10.1016\/j.ctro.2024.100870"},{"key":"10.1016\/j.ctro.2025.100918_b0090","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.ctro.2025.100918_b0095","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","article-title":"Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument (EPIC-26) for measuring health-related quality of life among prostate cancer survivors","volume":"76","author":"Szymanski","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ctro.2025.100918_b0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctro.2025.100918_b0105","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/cncr.25501","article-title":"Structural and reliability analysis of a patient satisfaction with cancer-related care measure: a multi-site patient navigation research program study","volume":"117","author":"Jean-Pierre","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2025.100918_b0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0272989X03256005","article-title":"Validation of a decision regret scale","volume":"23","author":"Brehaut","year":"2003","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ctro.2025.100918_b0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/art.10993","article-title":"The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research","volume":"49","author":"Sangha","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ctro.2025.100918_b0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.radonc.2021.12.047","article-title":"GEC-ESTRO ACROP prostate brachytherapy guidelines","volume":"167","author":"Henry","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2019.02.018","article-title":"Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study","volume":"135","author":"B\u00fcchser","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2021.12.027","article-title":"Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial","volume":"167","author":"Groen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.radonc.2008.12.007","article-title":"Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer","volume":"91","author":"Ghadjar","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clon.2017.01.042","article-title":"Long-term toxicity and health-related quality of life after single-fraction high dose rate brachytherapy boost and hypofractionated external beam radiotherapy for intermediate-risk prostate cancer","volume":"29","author":"Shahid","year":"2017","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0145","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2022.08.030","article-title":"The fraction size sensitivity of late genitourinary toxicity: analysis of alpha\/beta (\u03b1\/\u03b2) ratios in the CHHiP Trial","volume":"115","author":"Brand","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100918_b0150","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijrobp.2020.12.041","article-title":"Estimates of Alpha\/Beta (\u03b1\/\u03b2) ratios for individual late rectal toxicity endpoints: an analysis of the CHHiP Trial","volume":"110","author":"Brand","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100918_b0155","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ctro.2025.100918_b0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18590\/mjm.2018.vol4.iss2.9","article-title":"Effect of removing outliers on statistical inference: implications to interpretation of experimental data in medical research","volume":"4","author":"Gress","year":"2018","journal-title":"Marshall J Med"},{"key":"10.1016\/j.ctro.2025.100918_b0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prro.2013.02.011","article-title":"Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose","volume":"4","author":"Hsu","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2008.11.006","volume":"75","author":"Ishiyama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100918_b0175","first-page":"34","article-title":"Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer","volume":"31","author":"Kowalchuk","year":"2021","journal-title":"ctRO"},{"key":"10.1016\/j.ctro.2025.100918_b0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2005.10.003","article-title":"Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer- a phase II study","volume":"78","author":"Pinkawa","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jjco\/hyu173","article-title":"Correlation between the changes in the EPIC QOL scores and the dose-volume histogram parameters in high-dose-rate brachytherapy combined with hypofractionated external beam radiation therapy for prostate cancer","volume":"45","author":"Hashimoto","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0190","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1007\/s00345-023-04579-6","article-title":"State of the art and future challenges of urethra-sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature","volume":"41","author":"Guevelou","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.ctro.2025.100918_b0195","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.acra.2022.01.009","article-title":"Development of a 3D CNN-based AI model for automated segmentation of the prostatic urethra","volume":"29","author":"Belue","year":"2022","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ctro.2025.100918_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110513","article-title":"Fully automated radiotherapy treatment planning: A scan to plan challenge","author":"Gooding","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100918_b0205","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.brachy.2020.06.017","article-title":"Dose to the bladder neck is not correlated with urinary toxicity in patients with prostate cancer treated with HDR brachytherapy boost","volume":"19","author":"Ben Aicha","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2025.100918_b0210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.brachy.2019.02.003","article-title":"Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of life","volume":"18","author":"Sanmamed","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2025.100918_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2024.08.030","article-title":"Radical prostatectomy versus stereotactic radiotherapy for clinically localised prostate cancer: results of the PACE-a randomised trial","author":"van As","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2025.100918_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.08.023","article-title":"Image registration, contour propagation and dose accumulation of external beam and brachytherapy in gynecological radiotherapy","volume":"143","author":"Swamidas","year":"2020","journal-title":"Radiother Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T16:29:55Z","timestamp":1751214595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":44,"alternative-id":["S2405630825000084"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.100918","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of dose to the urethra and long-term patient-reported outcomes after radiotherapy with EBRT and HDR brachytherapy boost for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.100918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100918"}}